The Prevalence of Hepatitis C Virus Genotype 1A in Japan and Correlation Between the Mutations in the NS5A Region With Response to Pegylated-Interferon-Alpha 2B Plus Ribavirin Combination Therapy

被引：0
|
作者：
Hayashi, Kazuhiko
Katano, Yoshiaki
Ishigami, Masatoshi
Nakano, Isao
Itoh, Akihiro
Hirooka, Yoshiki
Goto, Hidemi
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T1986
引用
收藏
页码：S843 / S843
页数：1
相关论文
共 50 条
  • [21] Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy
    Yuan, H. J.
    Jain, M.
    Snow, K. K.
    Gale, M., Jr.
    Lee, W. M.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (03) : 208 - 216
  • [22] Mutations of the NS5B region in patients with chronic hepatitis C virus genotype 1b infection: Response to interferon alfa 2b and ribavirin
    Sugihara, K
    Orito, E
    Tanaka, Y
    Ohno, T
    Kato, T
    Mizokami, M
    HEPATOLOGY, 2004, 40 (04) : 331A - 331A
  • [23] Sequence Heterogeneity in NS5A of Hepatitis C Virus Genotypes 2a and 2b and Clinical Outcome of Pegylated-Interferon/Ribavirin Therapy
    El-Shamy, Ahmed
    Shoji, Ikuo
    Kim, Soo-Ryang
    Ide, Yoshihiro
    Imoto, Susumu
    Deng, Lin
    Yoon, Seitetsu
    Fujisawa, Takashi
    Tani, Satoshi
    Yano, Yoshihiko
    Seo, Yasushi
    Azuma, Takeshi
    Hotta, Hak
    PLOS ONE, 2012, 7 (02):
  • [24] Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy
    Veillon, Pascal
    Payan, Christopher
    Le Guillou-Guillemette, Helene
    Gaudy, Catherine
    Lunel, Francoise
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (08) : 1195 - 1203
  • [25] Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy
    Pascal Veillon
    Christopher Payan
    Hélène Le Guillou-Guillemette
    Catherine Gaudy
    Franoise Lunel
    World Journal of Gastroenterology, 2007, (08) : 1195 - 1203
  • [26] Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy
    Hamano, K
    Sakamoto, N
    Enomoto, N
    Izumi, N
    Asahina, Y
    Kurosaki, M
    Ueda, E
    Tanabe, Y
    Maekawa, S
    Itakura, J
    Watanabe, H
    Kakinuma, S
    Watanabe, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (09) : 1401 - 1409
  • [27] Mutations in the NS5A gene are associated with response to interferon plus ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection
    Ullah, Sajjad
    Rehman, Habib U.
    Idrees, Muhammad
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (10) : 1146 - 1151
  • [28] Real-Time Tissue Elastography for the Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C and Correlation With Response to Pegylated-Interferon-Alpha 2B and Ribavirin Combination Therapy
    Hayashi, Kazuhiko
    Katano, Yoshiaki
    Ishizu, Yoji
    Kuzuya, Teiji
    Honda, Takashi
    Ishigami, Masatoshi
    Goto, Hidemi
    GASTROENTEROLOGY, 2013, 144 (05) : S974 - S974
  • [29] Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus
    Hashimoto, Yuki
    Kanto, Hiromi
    Itoh, Masatoshi
    JOURNAL OF DERMATOLOGY, 2007, 34 (08): : 577 - 582
  • [30] Mutations in the E2 and NS5A Regions in Patients Infected With Hepatitis C Virus Genotype 1a and Their Correlation With Response to Treatment
    Yahoo, Neda
    Sabahi, Farzaneh
    Shahzamani, Kiana
    Malboobi, Mohamad Ali
    Jabbari, Hossain
    Sharifi, Houshang
    Mousavi-Fard, Seyed Hossein
    Merat, Shahin
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (08) : 1332 - 1337
12345